share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  09/27 04:18

牛牛AI助理已提取核心訊息

Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 09/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $42,004.78, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a pattern of previous sales over the past three months, where a total of 18,000 shares were sold for gross proceeds of $137,475.60.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 09/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $42,004.78, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a pattern of previous sales over the past three months, where a total of 18,000 shares were sold for gross proceeds of $137,475.60.
Recursion Pharmaceuticals, Inc.官員Marriott Tina計劃在2024年09月26日賣出6,000股A類股票,根據最新的申報文件。這些股票的總市值爲42,004.78美元,最初是通過2018年07月23日授予的期權獲得的。該交易將以現金進行。這次售出跟隨了過去三個月的歷史銷售模式,之前已售出總計18,000股,總收入爲137,475.60美元。
Recursion Pharmaceuticals, Inc.官員Marriott Tina計劃在2024年09月26日賣出6,000股A類股票,根據最新的申報文件。這些股票的總市值爲42,004.78美元,最初是通過2018年07月23日授予的期權獲得的。該交易將以現金進行。這次售出跟隨了過去三個月的歷史銷售模式,之前已售出總計18,000股,總收入爲137,475.60美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。